Successful Treatment With Vedolizumab in a Patient With Chronic Refractory Pouchitis and Primary Sclerosing Cholangitis

J Crohns Colitis. 2017 Dec 4;11(12):1507-1508. doi: 10.1093/ecco-jcc/jjx090.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Cholangitis, Sclerosing* / complications
  • Cholangitis, Sclerosing* / diagnosis
  • Colitis, Ulcerative* / complications
  • Colitis, Ulcerative* / diagnosis
  • Colitis, Ulcerative* / surgery
  • Gastrointestinal Agents / administration & dosage
  • Humans
  • Male
  • Pouchitis* / diagnosis
  • Pouchitis* / drug therapy
  • Proctocolectomy, Restorative / adverse effects*
  • Proctocolectomy, Restorative / methods
  • Remission Induction / methods
  • Symptom Assessment / methods
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Gastrointestinal Agents
  • vedolizumab